ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 172 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $11,210,574 | -47.2% | 5,049,808 | -36.3% | 0.11% | -45.1% |
| Q1 2024 | $21,231,574 | +2345.4% | 7,922,229 | +2628.2% | 0.20% | +2066.7% |
| Q4 2023 | $868,242 | +28.8% | 290,382 | -31.5% | 0.01% | 0.0% |
| Q1 2023 | $673,864 | -74.5% | 423,814 | 0.0% | 0.01% | -74.3% |
| Q4 2022 | $2,640,361 | -67.0% | 423,814 | -64.6% | 0.04% | -68.8% |
| Q3 2022 | $8,011,000 | +49.1% | 1,195,705 | +41.6% | 0.11% | +34.9% |
| Q2 2022 | $5,372,000 | – | 844,635 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $33,967,000 | 11.67% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $20,644,000 | 0.58% |
| Bellevue Group AG | 4,519,164 | $54,455,000 | 0.55% |
| Rhenman & Partners Asset Management AB | 622,267 | $7,498,000 | 0.53% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 47,534 | $573,000 | 0.21% |
| WASATCH ADVISORS LP | 3,274,360 | $39,456,000 | 0.16% |
| EMC Capital Management | 27,566 | $246,000 | 0.14% |
| PDT Partners, LLC | 120,828 | $1,456,000 | 0.10% |
| Virtus ETF Advisers LLC | 17,773 | $214,000 | 0.09% |
| Pinz Capital Management, LP | 15,300 | $184,000 | 0.08% |